Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis

计划入组 4 人 · 首次发布于 2021 年 2 月 23 日

Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis

计划入组 60 人 · 首次发布于 2019 年 11 月 26 日

Itolizumab for Relapsing Remitting Multiple Sclerosis

计划入组 40 人

liver disease program

Mitoxantrone

C₂₂H₂₈N₄O₆ · Rx

siRNA therapeutics for ocular disease/dermatological disease (Phio Pharmaceuticals)

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

Lupin Receives Tentative FDA Approval for Generic Siponimod Multiple Sclerosis Treatment

TG Therapeutics to Present New BRIUMVI Data in Multiple Sclerosis at ACTRIMS 2025 Forum

Zydus and Synthon Partner to Launch Generic Multiple Sclerosis Drug in $637 Million US Market